Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
Pluvicto is used to treat certain types of prostate cancer. It is a type of medicine called radioligand therapy. Common side effects include tiredness, dry mouth, nausea, decreased appetite, ...
Pluvicto is a radioligand therapeutic agent containing the active moiety, lutetium-177, which binds to PSMA, a transmembrane protein that is expressed in prostate cancer. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results